Silvio Däster
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
- Co-authors
- Raoul A. Droeser (19 shared papers)Manuele Giuseppe Muraro (8 shared papers)Savas D. Soysal (18 shared papers)Paul Zajac (4 shared papers)Simone Muenst (9 shared papers)Emanuele Trella (3 shared papers)William P. Weber (6 shared papers)Feng Gao (3 shared papers)
- Journals
- Langenbeck s Archives of Surgery (4 papers)Oncotarget (3 papers)BMC Cancer (3 papers)Disease Markers (2 papers)European Journal of Surgical Oncology (2 papers)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Silvio Däster
38 papers receiving 1.3k citations
Silvio Däster's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 727
- Immunology 356
- Cancer Research 146
- Pulmonary and Respiratory Medicine 139
- Biomedical Engineering 175
Countries citing papers authored by Silvio Däster
This map shows the geographic impact of Silvio Däster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvio Däster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvio Däster more than expected).
Fields of papers citing papers by Silvio Däster
This network shows the impact of papers produced by Silvio Däster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvio Däster. The network helps show where Silvio Däster may publish in the future.
Co-authors
The 25 scholars most cited alongside Silvio Däster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer Hit paper breakdown → | 2014 | 467 |
| 2 | 2016 | 201 | |
| 3 | 2017 | 160 | |
| 4 | 2012 | 57 | |
| 5 | 2019 | 42 | |
| 6 | 2015 | 39 | |
| 7 | 2014 | 34 | |
| 8 | 2013 | 31 | |
| 9 | 2019 | 28 | |
| 10 | 2018 | 28 | |
| 11 | 2019 | 20 | |
| 12 | 2014 | 15 | |
| 13 | 2020 | 15 | |
| 14 | 2015 | 15 | |
| 15 | 2016 | 12 | |
| 16 | 2017 | 11 | |
| 17 | 2022 | 10 | |
| 18 | 2017 | 10 | |
| 19 | 2021 | 9 | |
| 20 | 2022 | 8 |
About Silvio Däster
Silvio Däster is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Immunology and Biomedical Engineering, having authored 41 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Esophageal Cancer Research and Treatment (4 papers), 3D Printing in Biomedical Research (3 papers), Anorectal Disease Treatments and Outcomes (3 papers), Intestinal and Peritoneal Adhesions (2 papers), Hernia repair and management (2 papers) and Bariatric Surgery and Outcomes (2 papers). The work is most often cited by research in Oncology (727 citations), Immunology (356 citations), Cancer Research (146 citations), Pulmonary and Respiratory Medicine (139 citations) and Biomedical Engineering (175 citations). Silvio Däster has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Raoul A. Droeser, Manuele Giuseppe Muraro, Savas D. Soysal, Paul Zajac, Simone Muenst, Emanuele Trella, William P. Weber, Feng Gao, Giulio C. Spagnoli and Giandomenica Iezzi. Their work appears in journals such as Langenbeck s Archives of Surgery, Oncotarget, BMC Cancer, Disease Markers and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.